IGF2BP1 and cancer: However, evaluation of these candidate mRNAs provides strong evidence for the validity of the in silico studies and support the notion that IGF2BP1 is a conserved, post-transcriptional enhancer of pro-oncogenic factors in cancer cells due to primarily 3’UTR dependent stabilization of target mRNAs.